Walleye Trading LLC Allakos Inc. Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$2.6 - $6.14 $4,680 - $11,052	-1,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $5,588 - $10,791	1,100 Added 157.14%	1,800 $10,000
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $36,765 - $481,127	-4,300 Reduced 86.0%	700 $7,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $122,448 - $176,688	-1,600 Reduced 24.24%	5,000 $529,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $563,442 - $753,060	6,600 New	6,600 $563,000
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $899,786 - $1.26 Million	-8,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $652,556 - $1.25 Million	8,200 New	8,200 $1.15 Million
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $817,089 - $1.12 Million	-12,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $541,692 - $992,487	12,300 New	12,300 $884,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $74.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.